NORTHERN DATA AG (NB2.DE) Fundamental Analysis & Valuation

FRA:NB2 • DE000A0SMU87

Current stock price

10.58 EUR
+0.04 (+0.38%)
Last:

This NB2.DE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. NB2.DE Profitability Analysis

1.1 Basic Checks

  • NB2 had negative earnings in the past year.
  • NB2 had a negative operating cash flow in the past year.
  • In the past 5 years NB2 reported 4 times negative net income.
  • In multiple years NB2 reported negative operating cash flow during the last 5 years.
NB2.DE Yearly Net Income VS EBIT VS OCF VS FCFNB2.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M -400M -600M -800M -1B

1.2 Ratios

  • Looking at the Return On Assets, with a value of -5.08%, NB2 is doing worse than 67.54% of the companies in the same industry.
  • NB2 has a Return On Equity of -10.03%. This is in the lower half of the industry: NB2 underperforms 66.67% of its industry peers.
Industry RankSector Rank
ROA -5.08%
ROE -10.03%
ROIC N/A
ROA(3y)-27.09%
ROA(5y)-12.41%
ROE(3y)-36.56%
ROE(5y)-22.1%
ROIC(3y)N/A
ROIC(5y)N/A
NB2.DE Yearly ROA, ROE, ROICNB2.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -200 -400 -600

1.3 Margins

  • NB2 has a worse Gross Margin (37.20%) than 78.07% of its industry peers.
  • NB2's Gross Margin has improved in the last couple of years.
  • NB2 does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 37.2%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y9.08%
GM growth 5YN/A
NB2.DE Yearly Profit, Operating, Gross MarginsNB2.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -1K -2K -3K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. NB2.DE Health Analysis

2.1 Basic Checks

  • NB2 does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for NB2 has been increased compared to 1 year ago.
  • The number of shares outstanding for NB2 has been increased compared to 5 years ago.
  • Compared to 1 year ago, NB2 has a worse debt to assets ratio.
NB2.DE Yearly Shares OutstandingNB2.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
NB2.DE Yearly Total Debt VS Total AssetsNB2.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.2 Solvency

  • NB2 has an Altman-Z score of 1.24. This is a bad value and indicates that NB2 is not financially healthy and even has some risk of bankruptcy.
  • Looking at the Altman-Z score, with a value of 1.24, NB2 is doing worse than 63.16% of the companies in the same industry.
  • NB2 has a Debt/Equity ratio of 0.82. This is a neutral value indicating NB2 is somewhat dependend on debt financing.
  • The Debt to Equity ratio of NB2 (0.82) is worse than 78.95% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.82
Debt/FCF N/A
Altman-Z 1.24
ROIC/WACCN/A
WACC7.33%
NB2.DE Yearly LT Debt VS Equity VS FCFNB2.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M -1B

2.3 Liquidity

  • A Current Ratio of 2.69 indicates that NB2 has no problem at all paying its short term obligations.
  • NB2 has a better Current ratio (2.69) than 81.58% of its industry peers.
  • NB2 has a Quick Ratio of 2.69. This indicates that NB2 is financially healthy and has no problem in meeting its short term obligations.
  • The Quick ratio of NB2 (2.69) is better than 82.46% of its industry peers.
Industry RankSector Rank
Current Ratio 2.69
Quick Ratio 2.69
NB2.DE Yearly Current Assets VS Current LiabilitesNB2.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

7

3. NB2.DE Growth Analysis

3.1 Past

  • NB2 shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -480.00%.
  • NB2 shows a strong growth in Revenue. In the last year, the Revenue has grown by 61.65%.
  • NB2 shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 81.52% yearly.
EPS 1Y (TTM)-480%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-413.7%
Revenue 1Y (TTM)61.65%
Revenue growth 3Y1.8%
Revenue growth 5Y81.52%
Sales Q2Q%72.47%

3.2 Future

  • NB2 is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 23.12% yearly.
  • NB2 is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 23.74% yearly.
EPS Next Y-14.44%
EPS Next 2Y17.72%
EPS Next 3Y23.12%
EPS Next 5YN/A
Revenue Next Year4.91%
Revenue Next 2Y35.49%
Revenue Next 3Y34.68%
Revenue Next 5Y23.74%

3.3 Evolution

  • The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
NB2.DE Yearly Revenue VS EstimatesNB2.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 200M 400M 600M
NB2.DE Yearly EPS VS EstimatesNB2.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2018 2020 2021 2022 2023 2024 2025 2026 2027 0 -2 -4

More info and screens

Find the best growth stocksShow best growing peers

1

4. NB2.DE Valuation Analysis

4.1 Price/Earnings Ratio

  • NB2 reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Also next year NB2 is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
NB2.DE Price Earnings VS Forward Price EarningsNB2.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, NB2 is valued cheaper than 80.70% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 10.13
NB2.DE Per share dataNB2.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5 10 -10 -15

4.3 Compensation for Growth

  • A more expensive valuation may be justified as NB2's earnings are expected to grow with 23.12% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y17.72%
EPS Next 3Y23.12%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. NB2.DE Dividend Analysis

5.1 Amount

  • NB2 does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

NB2.DE Fundamentals: All Metrics, Ratios and Statistics

NORTHERN DATA AG

FRA:NB2 (3/16/2026, 7:00:00 PM)

10.58

+0.04 (+0.38%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)10-16
Earnings (Next)03-26
Inst Owners2.1%
Inst Owner ChangeN/A
Ins Owners8%
Ins Owner ChangeN/A
Market Cap679.24M
Revenue(TTM)16.38M
Net Income(TTM)-84.26M
Analysts77.14
Price Target29.33 (177.22%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-9.02%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-2.33%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-7.33%
Revenue NY rev (3m)-7.33%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 41.47
P/FCF N/A
P/OCF N/A
P/B 0.81
P/tB 0.85
EV/EBITDA 10.13
EPS(TTM)-7.25
EYN/A
EPS(NY)-2.33
Fwd EYN/A
FCF(TTM)-16.3
FCFYN/A
OCF(TTM)-0.91
OCFYN/A
SpS0.26
BVpS13.08
TBVpS12.51
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -5.08%
ROE -10.03%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 37.2%
FCFM N/A
ROA(3y)-27.09%
ROA(5y)-12.41%
ROE(3y)-36.56%
ROE(5y)-22.1%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y9.08%
GM growth 5YN/A
F-Score3
Asset Turnover0.01
Health
Industry RankSector Rank
Debt/Equity 0.82
Debt/FCF N/A
Debt/EBITDA 5.51
Cap/Depr 634.09%
Cap/Sales 6034.22%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.69
Quick Ratio 2.69
Altman-Z 1.24
F-Score3
WACC7.33%
ROIC/WACCN/A
Cap/Depr(3y)253.84%
Cap/Depr(5y)454.19%
Cap/Sales(3y)224.19%
Cap/Sales(5y)422.44%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-480%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-413.7%
EPS Next Y-14.44%
EPS Next 2Y17.72%
EPS Next 3Y23.12%
EPS Next 5YN/A
Revenue 1Y (TTM)61.65%
Revenue growth 3Y1.8%
Revenue growth 5Y81.52%
Sales Q2Q%72.47%
Revenue Next Year4.91%
Revenue Next 2Y35.49%
Revenue Next 3Y34.68%
Revenue Next 5Y23.74%
EBIT growth 1Y-255.81%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year303.58%
EBIT Next 3Y92.4%
EBIT Next 5YN/A
FCF growth 1Y-801.61%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-232.15%
OCF growth 3YN/A
OCF growth 5YN/A

NORTHERN DATA AG / NB2.DE Fundamental Analysis FAQ

What is the ChartMill fundamental rating of NORTHERN DATA AG (NB2.DE) stock?

ChartMill assigns a fundamental rating of 3 / 10 to NB2.DE.


What is the valuation status for NB2 stock?

ChartMill assigns a valuation rating of 1 / 10 to NORTHERN DATA AG (NB2.DE). This can be considered as Overvalued.


What is the profitability of NB2 stock?

NORTHERN DATA AG (NB2.DE) has a profitability rating of 1 / 10.


What is the financial health of NORTHERN DATA AG (NB2.DE) stock?

The financial health rating of NORTHERN DATA AG (NB2.DE) is 3 / 10.